Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (271-280 of 315) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|March 16, 2007
A comparison of allografting with autografting for newly diagnosed myelomaBenedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Blood|November 13, 2008
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesMarco Mielcarek, Barry E Storer, Michael Boeckh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosingMichael B Maris, Brenda M Sandmaier, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndromeRaya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2013
Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trialBrian Kornblit, David G Maloney, Rainer Storb, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
A preclinical model of double- versus single-unit unrelated cord blood transplantationGeorge E Georges, Vladimir Lesnikov, Szczepan W Baran, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Annals of Internal Medicine|January 21, 2020
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 CohortsGeorge B McDonald, Brenda M Sandmaier, Marco Mielcarek, et al.
Haematologica|September 29, 2018
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myelomaEnrico Maffini, Barry E Storer, Brenda M Sandmaier, et al.
Pageof 32

Showing results (271-280 of 315) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|March 16, 2007
A comparison of allografting with autografting for newly diagnosed myelomaBenedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Blood|November 13, 2008
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesMarco Mielcarek, Barry E Storer, Michael Boeckh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosingMichael B Maris, Brenda M Sandmaier, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndromeRaya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2013
Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trialBrian Kornblit, David G Maloney, Rainer Storb, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
A preclinical model of double- versus single-unit unrelated cord blood transplantationGeorge E Georges, Vladimir Lesnikov, Szczepan W Baran, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Annals of Internal Medicine|January 21, 2020
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 CohortsGeorge B McDonald, Brenda M Sandmaier, Marco Mielcarek, et al.
Haematologica|September 29, 2018
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myelomaEnrico Maffini, Barry E Storer, Brenda M Sandmaier, et al.
Pageof 32